Lithium carbonate: atomic absortion spectrophotometry in bioequivalence and pediatric pattern of use. / Carbonato de lítio: utilização da espectrofotometria de absorção atômica em bioequivalência e perfil de uso na pediatria.
AUTOR(ES)
Marcia Cristina Guimarães Guilherme
DATA DE PUBLICAÇÃO
2007
RESUMO
The ideal of this thesis is to benefit patients that use lithium, through two studies: (1) comparison of the bioavailability of two lithium formulations; and (2) investigation of lithium use in children and adolescents. In order to analyze the bioequivalence, healthy volunteers (N=24), of both genders, were treated with two lithium carbonate formulations (300 mg): test ? Neurolithium and reference-Carbolitium. After administrate each formulation in separate periods, plasma samples were collected to quantify lithium, using atomic absorption spectrophotometry. The method was developed specially to this study and it showed 0,07mg/L quantification limit. The geometric media and the 90% confiance interval test/reference was 104,77 (98,60-111,33%) to Cmax and 101,99 (96,81-107,44%) to ASClast. Based on FDA and ANVISA parameters, we concluded that Neurolithium is bioequivalent to Carbolitium. Therefore, this study assures the commercialization of a qualified formulation and makes possible the register of a generic medication with low cost. Since information regarding the safety and effectiveness of lithium in children under 12 years of age is not available, its use in such patients is not recommended at this time. Therefore, the second study has investigated the use of lithium in pediatric patients, divided in two groups: (A) under and (B) over 12 years old. Patients that received lithium prescription inside of HC in Unicamp, between 2000 and 2006, were identified. Only clinical register of patients (N=77) under 21 years old, were revised. Fewer doses were administrated in group A. Seric levels and side effects indexes were not different between groups. Group A showed reason for lithium prescription (aggressiveness) and effectiveness (71%) different from group B (humor oscillation; 83%). Since indexes effectiveness from both groups were in accordance with those found in literature and there was no difference in side effects number per patient, we concluded that the use of lithium in patients under 12 years old is feasible.
ASSUNTO(S)
bioequivalence bioequivalência lítio pediatry adolescentes crianças espectrofotometria de absorção atômica lithium uso atomic absorption spectrophotometry adolescents children
Documentos Relacionados
- Determinação sérica de lítio: comparação das metodologias de espectrometria de emissão e de absorção atômica
- Neurotoxicidade persistente secundária ao uso de lítio: relato de caso
- Nefropatia induzida por lítio: relato de caso
- Determinacao de selenio em figado bovino pela tecnica de geracao de hidretos: espectrofotometria de absorcao atomica.
- O uso de carbonato de lítio no tratamento da tireotoxicose induzida por amiodarona